Literature DB >> 15352650

How to use implantable intrathecal drug delivery systems for refractory cancer pain.

Thomas J Smith1, Patrick J Coyne.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2003        PMID： 15352650

Source DB:  PubMed          Journal:  J Support Oncol        ISSN： 1544-6794


× No keyword cloud information.
  4 in total

Review 1.  Intrathecal drug delivery for chronic pain management-scope, limitations and future.

Authors:  M Czernicki; G Sinovich; I Mihaylov; B Nejad; S Kunnumpurath; G Kodumudi; N Vadivelu
Journal:  J Clin Monit Comput       Date:  2014-08-31       Impact factor: 2.502

Review 2.  Neuraxial pain relief for intractable cancer pain.

Authors:  Paul A Sloan
Journal:  Curr Pain Headache Rep       Date:  2007-08

3.  Intrathecal long-term gene expression by self-complementary adeno-associated virus type 1 suitable for chronic pain studies in rats.

Authors:  Benjamin Storek; Nina M Harder; Michaela S Banck; Cheng Wang; Douglas M McCarty; William Gm Janssen; John H Morrison; Christopher E Walsh; Andreas S Beutler
Journal:  Mol Pain       Date:  2006-01-30       Impact factor: 3.395

Review 4.  Current perspectives on intrathecal drug delivery.

Authors:  Michael M Bottros; Paul J Christo
Journal:  J Pain Res       Date:  2014-11-06       Impact factor: 3.133
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.